6th Annual MarketsandMarkets Neuroscience R&D Technologies Conference

Unfolding the recent advancements in preclinical and translational approaches treating neurodegenerative disorders.

With the advent of neural implants and novel therapies, the cure of multiple neurodegenerative disorders proves wholesome for the patients’ suffering. Increasing in the severity of neurodegenerative diseases, demands the discovery of new translational approaches in neuroscience research.

Learn from 20+ industry leading speakers who will be sharing their presentations on CNS drug discovery, Latest Optogenetic tools, kinematic techniques, Blood-Brain Barrier Proteomics and Non-Invasive electrical brain stimulation.

Case studies presented from leading technology collaborations, Interactive panel and breakout sessions along with Access to online presentations on-demand post-summit.

First ever conference on application of technology in developing neurological treatments. Meet 100+ global heads of neuroscience from the industry and Academics.

Inflammation in multiple neurodegenerative diseases
Role of the glial cells in CNS disorders
Human iPSC for therapeutic approaches to the nervous system
New Approaches in development of anti – amyloid antibodies
Emerging Role of AI and big data in neuroscience
Disease modelling and drug discovery
Neural Implants and their role in brain monitoring
Future Predictions in drug development for Alzheimer’s disease

To share and exchange the recent trends and technologies in neuroscience R&D.
Participate in discussions with experts on how technology implementation can be improved.
To better understand neurological factors that will help in drug designing.
Discover how AI and big data advancements is boosting neuroscience developments.
Discover the various issues and challenges coming up in neuroscience research.
Gain Knowledge on the progress of neurodegenerative disorders and their possible treatments.
Opportunity for networking with professionals, delegates, and speakers.

Designations –

CEO
CSO
CMO
COO
President
Vice President
Director
Head of Department
Executive leader
Senior Manager
Manager
Principle Scientist
Scientist
Neuroscientist
Professor
Associate Professor
Lecturer
Researcher

Working in the department:

Neuroscience/CNS drug discovery
Pre-clinical research
Neurobiology
Neurotechnology
Neuroinflammation
Neuroimmunology
Neurodegenerative diseases
Translational Neuroscience
Neuropharmacology
Neuroimaging /Translational Imaging
AI and Big data in neuroscience
Computational Neuroscience
Neural Engineering
Neurophysiology

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson	08:55 - 09:00
Keynote Presentation	09:00 - 09:30
NEURODEGENERATION AND NOVEL THERAPEUTICS
Developments in Drug Discovery – Dealing with any kind of drugs related to major neurodegenerative disorders	09:30 - 10:00
Solution Provider Presentation	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
A framework for optimizing the value in neuroscience Simona Skerjanec, Senior VP and Therapeutic Area Head, Roche	11:15 - 11:45
Solution Provider Presentation	11:45 - 12:15
TRP channels in glia: therapeutic potential? Mark Dallus, Professor in cellular neuroscience, University of Reading	12:15 - 12:45
Systemic inflammation induced by lipopolysaccharide modulates Alzheimer’s disease progression. Marie Christine Pardon, Assistant Professor in Translational Neuroscience, University of Nottingham	12:45 - 13:15
Role of Genetics and epigenetics in Neurodegeneration	13:15 - 13:45
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:45 - 14:45
HUMAN IPSCS AND ANTIBODIES IN NEUROSCIENCE RESEARCH
Enabling precision medicine using human iPSC models and clinical research Zameel Cader, Professor of Neuroscience and Neurology, University of Oxford	14:45 - 15:15
Human neuronal networks on micro-electrode arrays are a robust tool to study disease phenotype in vitro Monica Frega, Assistant Professor, University of Twente	15:15 - 15:45
Use of human stem cell models of neurological disease to advance drug discovery Clare Jones, CSO, Talisman therapeutics	15:45 - 16:15
Evening Refreshments and Poster Presentation \| One-to-One Networking Meetings	16:15 - 17:15
Panel Discussion Session	17:15 - 18:00
Closing Remarks from the Chairperson	18:00 - 18:05
Drinks Reception & Networking	18:05 - 18:05
End of Day 1	18:05 - 18:05

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson	08:55 - 09:00
Keynote Presentation	09:00 - 09:30
INCLUSION OF AI AND DIGITAL BIOMARKERS
Artificial intelligence – Recognizing hidden patterns in human brain	09:30 - 10:00
Solution Provider Presentation	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
What role does digital health play in treating complex neural disorders?	11:15 - 11:45
Solution Provider Presentation	11:45 - 12:15
Digital Biomarker Strategies for Successful Development of Neuroscience Targets Jenny Barnett, CEO, Monument Therapeutics	12:15 - 12:45
Lunch and Poster Presentation \| One-to-One Networking Meetings	12:45 - 13:30
NEUROMODULATION AND FUTURE DEVELOPMENTS IN NEUROSCIENCE R&D
The future of neural implants to treat neurological conditions Patrick Degenaar, Professor in Neuroprosthetics, Newcastle University	13:30 - 14:00
Neuroengineering: the novel frontier for restoring neural functions Michela Chiappalone , Associate Professor, University of Genova	14:00 - 14:30
Drug Development for Neurodegenerative disorders	14:30 - 15:00
Development of Exoskeletons – Robotic limbs reproducing senses	15:00 - 15:30
Closing Remarks from the Chairperson	15:30 - 15:35
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:35 - 15:35
End of the conference	15:35 - 15:35